Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
SEKIDO, Net Income/Loss Unexpectedly Turn to Loss for Last Fiscal Year, Returning to Profitability This Year
9878 SEKIDO CO.,LTD 【J-GAAP】
Earnings ReportSEKIDO CO.,LTD <9878> [TSE Std] announced its financial results after the market closed on May 7th (16:00). The net income/loss (non-consolidated) for the fiscal year ending March 2025 turned into a loss of 581 million yen (compared to a profit of 47 million yen in the previous period consolidated), falling below the forecast of a 50 million yen, and tuning into a loss. For the fiscal year ending March 2026, the net income/loss is expected to recover to profit of 4 million yen.
At the same time, the company decided not to pay a dividend of 10 yen for the previous fiscal year, and plans to continue paying no dividends this fiscal year.
In the most recent three-month period, from January to March (4Q), the net loss expanded to a loss of 374 million yen (compared to a loss of 21 million yen in the previous period). The operating profit/loss margin drastically worsened from 1.6% in the same period last year to -8.6%.
Note: Since the fiscal year ending March 2025, the company has transitioned to non-consolidated financial statements.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 7,039 | 109 | 45 | -46 | -22.8 | 10 | May 2, 2023 | J-GAAP |
Mar, 2024 | 8,480 | 151 | 130 | 47 | 23.4 | 15 | May 7, 2024 | J-GAAP |
Mar, 2025 | 7,494 | -276 | -329 | -545 | -267.7 | 0 | May 7, 2025 | J-GAAP |
YoY | -11.6% | - | - | - | - |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Guidance | 8,700 | 152 | 72 | 50 | 24.5 | 10 | Mar 19, 2025 | J-GAAP |
Mar, 2025 Results | 7,494 | -276 | -329 | -545 | -267.7 | 0 | May 7, 2025 | J-GAAP |
Revision Rate | -13.9% | - | - | - | - |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Sep, 2024 | 4,025 | -44 | -63 | -99 | -48.7 | 0 | Nov 1, 2024 | J-GAAP |
Apr - Sep, 2025 Guidance | 3,440 | -55 | -83 | -93 | -35.2 | 0 | May 7, 2025 | J-GAAP |
YoY | -14.5% | -25.0% | -31.7% | +6.1% | +27.8% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2024 | 8,480 | 151 | 130 | 47 | 23.4 | 15 | May 7, 2024 | J-GAAP |
Mar, 2025 | 7,494 | -276 | -329 | -545 | -267.7 | 0 | May 7, 2025 | J-GAAP |
Mar, 2026 Guidance | 7,630 | 80 | 24 | 4 | 1.5 | 0 | May 7, 2025 | J-GAAP |
YoY | +1.8% | - | - | - | - |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Mar, 2024 | 2,282 | 36 | 19 | -21 | -10.5 | 1.6 | May 7, 2024 | J-GAAP |
Apr - Jun, 2024 | 2,023 | -45 | -62 | -69 | -34.0 | -2.2 | Aug 2, 2024 | J-GAAP |
Jul - Sep, 2024 | 2,002 | 1 | -1 | -30 | -14.8 | 0.0 | Nov 1, 2024 | J-GAAP |
Oct - Dec, 2024 | 1,720 | -82 | -103 | -108 | -53.3 | -4.8 | Jan 31, 2025 | J-GAAP |
Jan - Mar, 2025 | 1,749 | -150 | -163 | -338 | -166.0 | -8.6 | May 7, 2025 | J-GAAP |
YoY | -23.4% | - | - | -1,509.5% | -1,488.7% |
Related Articles
Insource, First Half Ordinary Profit Increases by 23%
KISSEI PHARMA, Last Fiscal Year's Ordinary Profit Unexpectedly Increases, 6% Increase in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 10 yen, This Fiscal Year to Increase Dividend by 20 yen
FRUTA FRUTA, Last Fiscal Year Ordinary Profit Revised Upward by 80%
SPARX Group, 4% Decrease in Ordinary Profit for the Last Fiscal Year, Current period performance is undisclosed.
Arisawa Mfg, 15% Decrease in Ordinary Profit for The Current Fiscal Year, Despite Last Fiscal Year's Dividend Increase, This Fiscal Year to Decrease Dividend
ShinMaywa, 3% Increase in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 2 yen, This Fiscal Year to Increase Dividend by 2 yen
NIHON DENGI, 1% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Dividend Effectively Increased
FUJI OOZX, 13% Increase in Ordinary Profit for The Current Fiscal Year
NANSIN, Last Fiscal Year Ordinary Profit Revised Downward to an Unexpected 0.4% Decrease
IDEA Consultants, Jan-Mar (1Q) Ordinary Profit Decreases by 6%